1. Home
  2. TEVA vs HLN Comparison

TEVA vs HLN Comparison

Compare TEVA & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$35.37

Market Cap

39.5B

Sector

Health Care

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$9.73

Market Cap

41.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEVA
HLN
Founded
1901
2022
Country
Israel
United Kingdom
Employees
32842
24524
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.5B
41.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TEVA
HLN
Price
$35.37
$9.73
Analyst Decision
Strong Buy
Buy
Analyst Count
8
1
Target Price
$38.63
N/A
AVG Volume (30 Days)
5.3M
10.5M
Earning Date
04-29-2026
02-26-2026
Dividend Yield
N/A
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.55
Revenue Next Year
$2.97
$4.42
P/E Ratio
$28.19
$49.05
Revenue Growth
N/A
N/A
52 Week Low
$14.99
$8.65
52 Week High
$37.35
$11.28

Technical Indicators

Market Signals
Indicator
TEVA
HLN
Relative Strength Index (RSI) 59.63 64.93
Support Level $30.59 $9.68
Resistance Level $35.33 $10.05
Average True Range (ATR) 1.13 0.14
MACD 0.20 0.09
Stochastic Oscillator 97.00 91.00

Price Performance

Historical Comparison
TEVA
HLN

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: